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(1:200, Sigma Aldrich) for 30 min at 37°C. Cells were washed in PBS three times, incubated with DAPI for 15 min at room temperature, washed with PBS and mounted as described above. For Rad51 staining ( Figure 5A ), cells were extracted and fixed as described above for RPA, and samples were sequentially stained with rabbit α-Rad51 (1:100, Santa Cruz), donkey α-rabbit-Al488 (1/500, Invitrogen), rabbit α-CENP-F (1:400; Santa Cruz) and sheep α-rabbit-Cy3 (1:200, Sigma Aldrich), each for 30 min at 37°C.
Immunoblotting
To determine the efficiency of siRNA knockdown, HeLa cells were sonicated in lysis buffer (50 mM Tris/HCl pH 8, 150 mM NaCl, 0.5% Natriumdesoxycholat, 1% TritonX100, 0.1% SDS and 1 x complete protease inhibitor cocktail) three times for 1 min and incubated for 30 min at 4˚C. Cell extracts were clarified by centrifugation for 30 min at 13,000 rpm. 1BRneo cells were lysed in lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 50 mM NaF, 30 mM β-glycerophosphate, 5 mM NaVO4, 0.2 % Triton X-100, 10% NP-40 and 1 x complete protease inhibitor cocktail) for 30 min at 4˚C. Cell extracts were clarified by centrifugation for 10 min at 13,000 rpm. Cell lysates were boiled in SDS loading buffer and 40-100 µg protein was separated using SDS-PAGE. Proteins were transfered to PVDF membrane and immunoblotting was carried out with primary antibody overnight at 4˚C, followed by secondary antibody for 1 h at room temperature. The immunoblots were developed using the ECL reagent (Lumi-Light Western Blotting Substrate, Roche Applied Science). The antibodies used are: α-Brca2 (Cell Signaling Technology, Beverly, MA, USA, #9012, 1:1000), α-Rad51 (Calbiochem, San Diego, CA, USA, PC130, 1:2000), α-Artemis (Novus Biologicals, Littleton, CO, USA, NB 100-542, 1:3000), α-ATM (Abcam, Cambridge, UK, ab31842, 1:500), α-Ku80 (Cell Signaling Technology, Beverly, MA, USA, #2180, 1:1000), α-Lig4 (Acris, Herford, Germany, SP1275, 1:1000), α-GAPDH and α-αTubulin (Santa Cruz, Santa Cruz, CA, USA, 1:1000).
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HR reporter assay
To determine the chromosomal HR frequency, NF-DRGP cells (SV40-transformed human skin fibroblasts) stably transfected with a single copy of the pDR-GFP construct were used (a generous gift from Simon Powell). They were grown in DMEM supplemented with 10% FCS, 20 mM Hepes, penicillin (100 I.U./ml), streptomycin (100 μg /ml) and puromycin (2.5 μg /ml).
Cells were transfected twice with 0.25 μM siRNA smart pool oligonucleotides (Dharmacon, for Brca2 and ATR knock-down or scrambled RNA; Qiagen, for Artemis knock-down) using Hiperfect transfection reagent (Qiagen). 24 h after the second siRNA transfection, cycling cells were transfected with pEGFP (transfection efficiency control) or pCMV3xnlsI-SceI (functional endonuclease) or phCMV-1 (negative control) using Genejuice reagent (Novagen). Transient expression of I-SceI endonuclease generates a DSB at the integrated GFP gene sequence and stimulates HR. GFP signal was assayed at 3 days post transfection by FACs. For each experiment, 100 000 cells were scored per treatment group and the frequency of recombination events was calculated from the number of GFP-positive cells divided by the transfection efficiency rate for each siRNA type. These values were then normalised so that cells transfected with scrambled RNA (CONT) + pIsceI vector showed 100% inducible GFP value.
Supplementary text to the legend of figure 8
The impact of D37N expression in HSF1 cells leads to a γH2AX repair defect that is slightly greater than loss of Artemis, a feature also observed by expressing D37N in the Artemis null cells. Thus, over-expressed D37N appears to have an effect which is slightly greater than simply inhibition of Artemis activity. Therefore, the slightly greater repair defect is potentially due to an additional impact of the endonuclease inactive D37N mutation on lesions not 4 otherwise repaired by HR as a consequence of high over-expression. This does not negate the fact that the D37N mutation is unable to complement Artemis null cells and that its overexpression prevents resection in control cells strongly suggesting that the endonuclease activity is required for Artemis function and efficient resection. showing that the activity of NU7026 remains unaffected over a 4-day incubation period.
